Cardiac comorbidity is not a risk factor for mortality and morbidity following surgery for primary non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 3, 2009, Pages 439-443

  Mishra, Pankaj Kumar ^a   Pandey, Ragini ^a   Shackcloth, Michael J ^a   McShane, James ^a   Grayson, Antony D ^a   Carr, Martyn H ^a   Page, Richard D ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Cardiac comorbidity; Lung cancer; Lung resection; Morbidity; Mortality

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; COMORBIDITY; CONGESTIVE HEART FAILURE; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; SURGICAL RISK;

AGE FACTORS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SMOKING;

EID: 60849100774     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.10.029     Document Type: Article

References (22)

1. Janssen- Heijnen M.L., Schipper R.M., Razenberg P.P., Crommelin M.A., and Coebergh J.W. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population based study. Lung Cancer 21 (1998) 105-113
2. Deslauriers J., Ginsberg R.J., Piantadosi S., and Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest 106 December (6 Suppl.) (1994) 329S-330S
3. Reicher-Reiss H., Jonas M., Goldbourt U., Boyko V., and Modan B. Selectively increased risk of cancer in men with coronary heart disease. Am J Cardiol 87 February (4) (2001) 459-462
4. Licker M., de Perrot M., Hohn L., Tschopp J.M., Robert J., Frey J.G., Schweizer A., and Spiliopoulos A. Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg 15 March (3) (1999) 314-319
5. Thomas P., Giudicelli R., Guillen J.C., and Fuentes P. Is lung cancer surgery justified in patients with coronary artery disease?. Eur J Cardiothorac Surg 8 6 (1994) 287-292
6. Moro-Sibilot D., Aubert A., Diab S., Lantuejoul S., Fourneret P., Brambilla E., Brambilla C., and Brichon P.Y. Comorbidities and Charlson score in resected stage I non-small cell lung cancer. Eur Respir J 26 September (3) (2005) 480-486
7. Myrdal G., Gustafsson G., Lambe M., Hörte L.G., and Ståhle E. Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity. Eur J Cardiothorac Surg 20 October (4) (2001) 694-699
8. Ambrogi V., Pompeo E., Elia S., Pistolese G.R., and Mineo T.C. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small cell lung cancer. Eur J Cardiothorac Surg 23 May (5) (2003) 811-817
9. British Thoracic Society. Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001;56:89-108.
10. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc 53 (1958) 547-581
11. Blackstone E.H. Comparing apples and oranges. J Thorac Cardiovasc Surg 123 (2002) 8-15
12. Hosmer D., and Lemeshow S. Applied logistic regression (1989), John Wiley & Sons Inc., New York, NY
13. Nesbitt J.C., Putnam Jr. J.B., Walsh G.L., Roth J.A., and Mountain C.F. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 60 2 (1995) 466-472
14. Read R.C., Yoder G., and Schaeffer R.C. Survival after conservative resection for T1 N0 M0 non-small cell lung cancer. Ann Thorac Surg 49 3 (1990) 391-400
15. Charlson M.E., Pompei P., and Ales K.L. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 378-383
16. Lopez-Encuentra A. Comorbidity in operable lung cancer. A multicentre descriptive study on 2992 patients. Lung Cancer 35 (2002) 263-269
17. Duque J.L., Ramos G., Castrodeza J., Cerezal J., Castanedo M., Yuste M.G., and Heras F. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Ann Thorac Surg 63 April (4) (1997) 944-950
18. Ginsberg R.J., Hill L.D., Eagan R.T., Thomas P., Mountain C.F., Deslauriers J., Fry W.A., Butz R.O., Goldberg M., and Waters P.F. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86 November (5) (1983) 654-658
19. Devereaux P.J., Goldman L., Yusuf S., Gilbert K., Leslie K., and Guyatt G.H. Surveillance and prevention of major perioperative ischaemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ 173 September (7) (2005) 779-788
20. ACC/AHA Task Force. Guidelines for perioperative cardiovascular evaluation for non-cardiac surgery. Report of the ACC/AHA Task Force on practice guidelines. Circulation 1996;93:1278-1317.
21. Decker K.D., Jorens P.G., and Schil P.V. Cardiac complications after noncardiac thoracic surgery: an evidence-based current review. Ann Thorac Surg 75 (2003) 1340-1348
22. Beattie W.S., Badner N.H., and Choi P.T. Meta-analysis demonstrates statistically significant reduction in postoperative myocardial infarction with the use of thoracic epidural analgesia. Anesth Analg 97 September (3) (2003) 919-920